| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Emapunil；AC-5216;XBD-173 |
AC-5216 |
226954-04-7 |
详细
|
| Ponatinib；AP24534 |
帕纳替尼 |
943319-70-8 |
详细
|
| Liproxstatin-1 |
利普司他丁-1 |
950455-15-9 |
详细
|
| HTH-01-015 |
无中文名称 |
1613724-42-7 |
详细
|
| Vipadenant；BIIB-014;CEB-4520 |
3-(4-氨基-3-甲基苄基)-7-(呋喃-2-基)-3H-[1,2,3]三唑并[4,5-D]嘧啶-5-胺 |
442908-10-3 |
详细
|
| BX471；ZK-811752;BX 471;BX-471 |
(R)-1-(5-氯-2-(2-(4-(4-氟苄基)-2-甲基哌嗪-1-基)-2-氧代乙氧基)苯基)脲 |
217645-70-0 |
详细
|
| Pilaralisib analogue；XL147 analogue;SAR245408 |
XL147 |
956958-53-5 |
详细
|
| Vemurafenib；PLX4032;RO5185426;RG7204 |
维罗非尼 |
918504-65-1 |
详细
|
| Pomalidomide；CC-4047 |
泊马度胺 |
19171-19-8 |
详细
|
| RGB-286638 free base |
N-[1,4-二氢-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-吗啉基脲 |
784210-88-4 |
详细
|
| Panobinostat；NVP-LBH589;LBH589 |
帕比司他 |
404950-80-7 |
详细
|
| BIBR 1532 |
2-[[(2E)-3-(2-萘基)-1-氧代-2-丁烯基]氨基]苯甲酸 |
321674-73-1 |
详细
|
| Abemaciclib；LY2835219;CDK4/6 dual inhibitor |
阿贝西利 |
1231929-97-7 |
详细
|
| UNC1215 |
UNC1215 |
1415800-43-9 |
详细
|
| Ipragliflozin；ASP1941 |
伊格列净 |
761423-87-4 |
详细
|
| Topiroxostat；FYX-051 |
托匹司他 |
577778-58-6 |
详细
|
| Cevimeline hydrochloride hemihydrate |
盐酸西维美林 |
153504-70-2 |
详细
|
| Pixantrone dimaleate；BBR 2778 dimaleate;Pixantrone Maleate;BBR-2778 |
马来到匹杉琼 |
144675-97-8 |
详细
|
| Pirfenidone；S-7701,AMR-69;AMR69;S-7701 |
吡非尼酮 |
53179-13-8 |
详细
|
| Ramatroban；BAY u3405 |
雷马曲班 |
116649-85-5 |
详细
|
| Vortioxetine；Lu AA 21004 |
沃替西汀 |
508233-74-7 |
详细
|
| Efavirenz；Sustiva;Stocrin;DMP 266;EFV;L-743726 |
依法韦仑 |
154598-52-4 |
详细
|
| Nalfurafine hydrochloride；TRK-820 hydrochloride |
盐酸纳呋拉啡 |
152658-17-8 |
详细
|
| Vortioxetine hydrobromide；Vortioxetine HBr;Lu AA21004 hydrobromide;Vortioxetine (Lu AA21004) HBr |
氢溴酸沃替西汀 |
960203-27-4 |
详细
|
| Glycopyrrolate；Glycopyrronium bromide;Robinul;Glycopyrrolate bromide;Gastrodyn |
格隆溴铵 |
596-51-0 |
详细
|
| Camostat mesylate；Camostat mesilate;FOY305;FOY-S980 |
甲磺酸卡莫司他 |
59721-29-8 |
详细
|
| Bortezomib；MG 341;DPBA;Brotezamide;NSC 681239;Radiciol;LDP 341 |
硼替佐米 |
179324-69-7 |
详细
|
| Dapagliflozin；BMS-512148 |
达格列净 |
461432-26-8 |
详细
|
| Tofacitinib Citrate；Tasocitinib citrate;Tofacitinib (CP-690550) Citrate;CP-690550 citrate |
枸橼酸托法替尼 |
540737-29-9 |
详细
|
| Nafamostat mesylate；FUT-175 |
甲磺酸萘莫司他 |
82956-11-4 |
详细
|
| Luliconazole；NND 502 |
卢立康唑 |
187164-19-8 |
详细
|
| BMS-794833；BMS794833 |
BMS-794833 |
1174046-72-0 |
详细
|
| P 22077；P22077 |
P 22077 |
1247819-59-5 |
详细
|
| P7C3-A20 |
P7C3-A20 |
1235481-90-9 |
详细
|
| Candesartan Cilexetil；TCV-116 |
坎地沙坦酯 |
145040-37-5 |
详细
|
| SRT1720 hydrochloride；SRT1720 HCl;SRT 1720 Hydrochloride |
SRT1720 |
1001645-58-4 |
详细
|
| Vonoprazan fumarate；TAK-438 |
富马酸沃诺拉赞 |
1260141-27-2 |
详细
|
| TG6-10-1 |
TG6-10-1 |
1415716-58-3 |
详细
|
| PP121 |
PP121 |
1092788-83-4 |
详细
|
| A66 |
A66 |
1166227-08-2 |
详细
|
| Nedaplatin；NSC 375101D |
奈达铂 |
95734-82-0 |
详细
|
| BIX02189 |
3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯基亚甲基]-2,3-二氢-N,N-二甲基-2-氧代-1H-吲哚-6-甲酰胺 |
1094614-85-3 |
详细
|
| Alogliptin Benzoate；Alogliptin(SYR-322)benzoate;SYR 322 |
苯甲酸阿格列汀 |
850649-62-6 |
详细
|
| FH535 |
2,5-二氯-N-(2-甲基-4-硝基苯基)苯磺酰胺 |
108409-83-2 |
详细
|
| PHT-427；PHT 427;CS-0223;PHT427 |
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 |
1191951-57-1 |
详细
|
| PNU-282987；PNU 282987 |
PNU-282987 |
123464-89-1 |
详细
|
| Cinacalcet hydrochloride；AMG-073 HCl;AMG-073 hydrochloride;Cinacalcet;Cinacalcet HCl |
盐酸甲状旁腺激素 |
364782-34-3 |
详细
|
| PD 169316 |
4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶 |
152121-53-4 |
详细
|
| Tenofovir Disoproxil Fumarate；GS-1278 Disoproxil Fumarate;Tenofovir DF |
富马酸替诺福韦酯 |
202138-50-9 |
详细
|
| Revaprazan hydrochloride；YH1885 |
盐酸瑞伐拉赞 |
178307-42-1 |
详细
|
| Bromfenac sodium hydrate；Bromfenac sodium;Bromfenac monosodium salt sesquihydrate |
(2-氨基-3-(4-溴苯甲酰)苯基)乙酸钠 |
120638-55-3 |
详细
|
| ID-8；ID 8;ID8 |
1-(4-甲氧基苯基)-2-甲基-3-硝基-1H-吲哚-6-醇 |
147591-46-6 |
详细
|
| EHop-016；EHop016;EHop 016 |
EHOP-016;N4-(9-ETHYL-9H-CARBAZOL-3-YL)-N2-(3-MORPHOLIN-4-YL-PROPYL)-PYRIMIDINE-2,4-DIAMINE |
1380432-32-5 |
详细
|
| Olverembatinib dimesylate；HQP1351;GZD824 Dimesylate |
GZD824DIMESYLATE |
1421783-64-3 |
详细
|
| HPOB |
HDAC6抑制剂 |
1429651-50-2 |
详细
|
| NU 7026；DNA-PK Inhibitor II;LY293646;NU7026 |
2-(4-吗啉基)-4H-萘并[1,2-B]吡喃-4-酮 |
154447-35-5 |
详细
|
| Torkinib；PP 242 |
PP242 |
1092351-67-1 |
详细
|
| Sal003 |
(2E)-3-苯基-N-[2,2,2-三氯-1-[[[(4-氯苯基)氨基]硫代甲酰基]氨基]乙基]-2-丙烯酰胺 |
1164470-53-4 |
详细
|
| Tenofovir alafenamide；GS-7340 |
泰诺福韦艾拉酚胺 |
379270-37-8 |
详细
|
| SKLB1002 |
SKLB1002 |
1225451-84-2 |
详细
|
| Tianeptine sodium salt；Tianeptine sodium |
噻奈普汀钠盐 |
30123-17-2 |
详细
|
| Tiagabine；Gabitril;NO050328;NO328;TGB |
噻加宾 |
115103-54-3 |
详细
|
| R406 free base；R406 (free base) |
R-406 |
841290-80-0 |
详细
|
| SB-505124；SB 505124;SB505124 |
SB-505124 |
694433-59-5 |
详细
|
| PIK-90；PIK 90;PIK90 |
N-(2,3-二氢-7,8-二甲氧基咪唑并[1,2-C]喹唑啉-5-基)-3-吡啶甲酰胺 |
677338-12-4 |
详细
|
| CI-1040；CI1040;PD 184352;CI 1040 |
2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺 |
212631-79-3 |
详细
|
| D4476；D 4476;Casein Kinase I Inhibitor |
4-[4-(2,3-二氢-1,4-苯并二氧杂环己-6-基)-5-(2-吡啶基)-1H-咪唑-2-基]苯甲酰胺 |
301836-43-1 |
详细
|
| Dacinostat；LAQ824;NVP-LAQ824 |
达诺司他 |
404951-53-7 |
详细
|
| SANT-1；SANT1;SANT 1 |
SANT1 |
304909-07-7 |
详细
|
| Osu03012；Osu-03012;Osu 03012;AR-12 |
2-氨基-N-[4-[5-(2-菲基)-3-(三氟甲基)-1H-吡唑-1-基]苯基]乙酰胺 |
742112-33-0 |
详细
|
| CH-223191；CH 223191 |
1-甲基-N-[2-METHYL-4-[2-(2-甲苯基)二氮烯基]苯基-1H-吡唑-5-甲酰胺 |
301326-22-7 |
详细
|
| CID755673 |
2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one |
521937-07-5 |
详细
|
| HMN-214；HMN214;IVX-214 |
(E)-4-[2-[2-[N-乙酰基-N-[(4-甲氧基苯基)磺酰]氨基]苯基]乙烯基]吡啶 1-氧化物 |
173529-46-9 |
详细
|
| IC261；SU-5607 |
3-(2,4,6-三甲氧基苯亚甲基)吲哚啉-2-酮 |
186611-52-9 |
详细
|
| TAS-301；TAS 301;TAS301 |
3-(双(4-甲氧基苯基)亚甲基)吲哚啉-2-酮 |
193620-69-8 |
详细
|
| BRL 54443；BRL54443 |
3-(1-甲基-4-哌啶基)-1H-吲哚-5-醇 |
57477-39-1 |
详细
|
| A-769662；A 769662 |
4-羟基-3-(2'-羟基-1,1'-联苯-4-基)-6-氧代-6,7-二氢噻吩并[2,3-B]吡啶-5-甲腈 |
844499-71-4 |
详细
|
| MDL-28170；Calpain Inhibitor III |
MDL 28170 |
88191-84-8 |
详细
|
| AZD7545 |
4-[[3-氯-4-[[(2R)-3,3,3-三氟-2-羟基-2-甲基-1-氧代丙基]氨基]苯基]磺酰基]-N,N-二甲基苯甲酰胺 |
252017-04-2 |
详细
|
| TP808；TP 808;TP-808 |
TP808 |
852821-06-8 |
详细
|
| LY 303511 |
8-苯基-2-(1-哌嗪基)-4H-1-苯并吡喃-4-酮 |
154447-38-8 |
详细
|
| KNK437；Heat Shock Protein Inhibitor I |
KNK437 |
218924-25-5 |
详细
|
| NSC319726；ZMC1 |
NSC319726 |
71555-25-4 |
详细
|
| MK-8745；MK8745 |
MK8745 |
885325-71-3 |
详细
|
| GSK2801 |
GSK2801 |
1619994-68-1 |
详细
|
| EPZ011989 |
化合物EPZ011989 |
1598383-40-4 |
详细
|
| GlyH-101；GlyH 101;GlyH101 |
GLYH 101 |
328541-79-3 |
详细
|
| C646 |
C646 |
328968-36-1 |
详细
|
| FG-2216；FG 2216;YM-311;FG2216 |
BIQ |
223387-75-5 |
详细
|
| KI8751 |
Ki8751 |
228559-41-9 |
详细
|
| PF-562271；PF562271;PF 562271 |
N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺 |
717907-75-0 |
详细
|
| PLX-4720；PLX4720 |
N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺 |
918505-84-7 |
详细
|
| ML141；CID-2950007 |
ML 141 |
71203-35-5 |
详细
|
| PFK-015；PFK15;PFK 015;PFK015 |
PFK-015 |
4382-63-2 |
详细
|
| IRAK-1-4 Inhibitor I；IRAK-1/4 Inhibitor I;IRAK-1/4 Inhibitor |
IRAK-1-4 抑制剂 I |
509093-47-4 |
详细
|
| Tivozanib；AV-951;KRN951 |
替沃扎尼 |
475108-18-0 |
详细
|
| CGI-1746；CGI1746 |
N-[3-[4,5-二氢-4-甲基-6-[[4-(4-吗啉基羰基)苯基]氨基]-5-氧代-2-吡嗪基]-2-甲基苯基]-4-(叔丁基)苯甲酰胺 |
910232-84-7 |
详细
|
| O4I1 |
2-(4-[(4-甲氧基苄基)氧基]苯基)乙腈 |
175135-47-4 |
详细
|
| CPI203；CPI 203;CPI-203 |
4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-乙酰胺 |
202591-23-9 |
详细
|
| O4I2 |
O4I2 |
165682-93-9 |
详细
|